Attogene, a biotechnology firm in Austin, TX is announcing expansion of its product line to address the rapidly evolving testing demands within the United States, these efforts can have significant public health impact particularly as SARS-CoV-2 continues to mutate around the world.
Attogene to expand SARS-CoV-2
variants testing in the United States
Attogene, a biotechnology company based in
Austin, Texas, expands its product line to
address the rapidly evolving testing demands
within the United States, these efforts can
have significant public health impact
particularly as SARS-CoV-2 continues to
mutate around the world.
Specifically, Attogene will now
distribute Novacyt's eight RUO assays,
which arguably may be the most
complete variant detection portfolio
currently available worldwide to
address the globally prevalent variants
of SARS-CoV-2.
Novacyt will also have
available a new RUO assay
to detect a novel variant
originally identified in India.
Attogene's focus/mission is to
provide cutting edge products
and services to address
major environmental
concerns globally.
Attogene enhances health and
wellness of plants, animals and
the environment by offering and
developing customer focused Life
Science Products domestically
and internationally.
Attogene has additional
products and services to
address the growing threat
from cyanotoxins associated
by harmful algae blooms.
Attogene.com The Novacyt
Group is an international
diagnostics business
generating an increasing
portfolio of in vitro and
molecular diagnostic tests.
Its core strengths lie in
diagnostics product
development,
commercialization, contract
design and manufacturing.
The Company's lead business
units comprise of Primerdesign
and Lab21 Products, supplying
an extensive range of high-
quality assays and reagents
worldwide.
The Group directly offers
microbiology, hematology and
serology products with a
focus in respiratory and
transplantation markets.
Contact Us At:
https://www.attogene
.com/
variants testing in the United States
Attogene, a biotechnology company based in
Austin, Texas, expands its product line to
address the rapidly evolving testing demands
within the United States, these efforts can
have significant public health impact
particularly as SARS-CoV-2 continues to
mutate around the world.
Specifically, Attogene will now
distribute Novacyt's eight RUO assays,
which arguably may be the most
complete variant detection portfolio
currently available worldwide to
address the globally prevalent variants
of SARS-CoV-2.
Novacyt will also have
available a new RUO assay
to detect a novel variant
originally identified in India.
Attogene's focus/mission is to
provide cutting edge products
and services to address
major environmental
concerns globally.
Attogene enhances health and
wellness of plants, animals and
the environment by offering and
developing customer focused Life
Science Products domestically
and internationally.
Attogene has additional
products and services to
address the growing threat
from cyanotoxins associated
by harmful algae blooms.
Attogene.com The Novacyt
Group is an international
diagnostics business
generating an increasing
portfolio of in vitro and
molecular diagnostic tests.
Its core strengths lie in
diagnostics product
development,
commercialization, contract
design and manufacturing.
The Company's lead business
units comprise of Primerdesign
and Lab21 Products, supplying
an extensive range of high-
quality assays and reagents
worldwide.
The Group directly offers
microbiology, hematology and
serology products with a
focus in respiratory and
transplantation markets.
Contact Us At:
https://www.attogene
.com/